Virovek Now Delivers AAVs in HEK293 Cells

Hayward, California – March 10, 2021 Virovek is pleased to launch a new service line, producing adeno-associated virus (AAV) vector in human embryonic kidney HEK293 cells through three plasmid transfection method. See our HEK293 page for more details and...

Bio-manufacturing and processing summit (ManuBio USA 2013)

Boston, Massachusetts, June 10-11, 2013 — Virovek was invited to present and showcase its large-scale AAV vector manufacturing process at this inaugural bio-manufacturing and processing summit (ManuBio USA 2013) to an audience composed of senior level delegates...

Virovek’s latest suicide gene therapy technology

Nanjing, China, April 25-27, 2013 — Company CEO, Dr. Haifeng Chen, chaired the Gene Therapy session and presented Virovek’s latest suicide gene therapy technology using toxins to target cancer cells at the BIT’s 4th Annual World DNA and Genome Day...